Background Background Irritable bowel
Irritable bowel syndrome syndrome often leads to impaired often leads to impaired functioning. functioning.
Aims Aims To assess the contribution of
To assess the contribution of psychiatric disorders to impaired outcome psychiatric disorders to impaired outcome in severe irritable bowel syndrome. in severe irritable bowel syndrome.
Method Method Patients with severe irritable
Patients with severe irritable bowel syndrome entering a psychological bowel syndrome entering a psychological treatmenttrial ( treatmenttrial (n n¼257) were interviewed 257) were interviewed using the Schedules for Clinical using the Schedules for Clinical Assessment in Neuropsychiatry. Assessment in Neuropsychiatry. Outcomes were number of days of Outcomes were number of days of restricted activity, role limitation restricted activity, role limitation (physical) score of the Short Form Health (physical) score of the Short Form Health Survey and costs. Survey and costs.
Results

Results At baseline, depressive
At baseline, depressive disorder (29% of patients), panic (12%) disorder (29% of patients), panic (12%) and neurasthenia (35%) were associated and neurasthenia (35%) were associated with impairment; number of psychiatric with impairment; number of psychiatric disorders was associated in a dosedisorders was associated in a doser esponse fashion ( response fashion (P P¼0.005). At follow-up, 0.005). At follow-up, depressive disorder and neurasthenia depressive disorder and neurasthenia were associated with role limitation score. were associated with role limitation score. Improved depression was associated with Improved depression was associated with improved role functioning. improved role functioning.
Conclusions Conclusions Depressive, panic and
Depressive, panic and neurasthenic disorders contribute to poor neurasthenic disorders contribute to poor outcomes in severe irritable bowel outcomes in severe irritable bowel syndrome, and appropriate treatment syndrome, and appropriate treatment should be available to these patients. should be available to these patients.
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Irritable bowel syndrome is the major cause Irritable bowel syndrome is the major cause of referrals to gastroenterology clinics in of referrals to gastroenterology clinics in the Western world, at an estimated cost of the Western world, at an estimated cost of $8 billion per annum in the USA (Thomp-$8 billion per annum in the USA ( Thompson son et al et al, 2002) . Psychiatric disorders occur , 2002) . Psychiatric disorders occur in 50-60% of these clinic patients and conin 50-60% of these clinic patients and contribute to impaired health-related quality of tribute to impaired health-related quality of life and increased medical help-seeking life and increased medical help-seeking (Creed, 1999; Creed (Creed, 1999; Creed et al et al, 2001; American , 2001; American Gastroenterology Association, 2002) . It is Gastroenterology Association, 2002). It is not clear, however, which psychiatric disnot clear, however, which psychiatric disorders contribute to these poor outcomes orders contribute to these poor outcomes in irritable bowel syndrome and no treatin irritable bowel syndrome and no treatment trial has yet matched type of treatment ment trial has yet matched type of treatment to specific psychiatric disorders in this to specific psychiatric disorders in this population. We have shown that psychopopulation. We have shown that psychodynamic interpersonal therapy and dynamic interpersonal therapy and pharmacotherapy with a selective serotonin pharmacotherapy with a selective serotonin reuptake inhibitor (paroxetine) each led to reuptake inhibitor (paroxetine) each led to improved health-related quality of life in improved health-related quality of life in patients with severe irritable bowel patients with severe irritable bowel syndrome, compared with usual treatment, syndrome, compared with usual treatment, without additional healthcare costs (Creed without additional healthcare costs (Creed et al et al, 2003) . In this study we examined , 2003) . In this study we examined the extent to which particular psychiatric the extent to which particular psychiatric disorders contribute to impairment of role disorders contribute to impairment of role function and high costs at the start of the function and high costs at the start of the trial and at follow-up. We predicted that trial and at follow-up. We predicted that after controlling for severity of abdominal after controlling for severity of abdominal pain, the presence of one or more psychipain, the presence of one or more psychiatric disorders at baseline would be assoatric disorders at baseline would be associated with greater impairment in daily ciated with greater impairment in daily activities, reduced ability to work and activities, reduced ability to work and higher costs. We tested this hypothesis both higher costs. We tested this hypothesis both at baseline (trial entry) and at follow-up (15 at baseline (trial entry) and at follow-up (15 months later). We also predicted that the months later). We also predicted that the number of psychiatric disorders would be number of psychiatric disorders would be significantly associated with degree of significantly associated with degree of impairment at both trial entry and at impairment at both trial entry and at follow-up, and that reduction of psychiatric follow-up, and that reduction of psychiatric symptoms would be associated with symptoms would be associated with reductions in impairment and costs. reductions in impairment and costs.
METHOD METHOD
We recruited patients from three secondary We recruited patients from three secondary and four tertiary level gastroenterology and four tertiary level gastroenterology clinics around Manchester and Sheffield in clinics around Manchester and Sheffield in the UK. Patients were invited to enter a the UK. Patients were invited to enter a randomised controlled trial, which involved randomised controlled trial, which involved random allocation to eight sessions of indirandom allocation to eight sessions of individual psychotherapy over 12 weeks, 20 mg vidual psychotherapy over 12 weeks, 20 mg daily of the selective serotonin reuptake daily of the selective serotonin reuptake inhibitor (SSRI) antidepressant, paroxetine, inhibitor (SSRI) antidepressant, paroxetine, for 12 weeks or continued routine care by for 12 weeks or continued routine care by the patient's gastroenterologist and primary the patient's gastroenterologist and primary care physician (Creed care physician (Creed et al et al, 2003) . The , 2003) . The same outcome measurements were made same outcome measurements were made at baseline (trial entry) and at follow-up 1 at baseline (trial entry) and at follow-up 1 year after the completion of the treatment year after the completion of the treatment period (i.e. 15 months after trial entry). period (i.e. 15 months after trial entry).
All people attending the clinics with All people attending the clinics with irritable bowel syndrome were screened irritable bowel syndrome were screened and those who fulfilled the inclusion criterand those who fulfilled the inclusion criteria were invited to enter the trial. These were ia were invited to enter the trial. These were patients 18-65 years old who fulfilled the patients 18-65 years old who fulfilled the Rome I criteria for this syndrome (ThompRome I criteria for this syndrome ( Thompson son et al et al, 1992) , with symptoms for 6 , 1992), with symptoms for 6 months or more and a pain severity score months or more and a pain severity score of more than 59 on a 0 to 100 visual anaof more than 59 on a 0 to 100 visual analogue scale, who had not responded to logue scale, who had not responded to 'usual' medical treatment including edu-'usual' medical treatment including education, dietary advice, and antispasmodic cation, dietary advice, and antispasmodic and laxatives or antidiarrhoeal medication. and laxatives or antidiarrhoeal medication. We excluded patients who were unable to We excluded patients who were unable to complete questionnaires in English, who complete questionnaires in English, who had a psychotic disorder, severe personality had a psychotic disorder, severe personality disorder or active suicidal ideation, or had disorder or active suicidal ideation, or had a contraindication either to psychotherapy a contraindication either to psychotherapy or to taking an SSRI (e.g. taking medication or to taking an SSRI (e.g. taking medication that could interact with an SSRI, such as that could interact with an SSRI, such as sumatriptan, warfarin and anticonvulsants). sumatriptan, warfarin and anticonvulsants).
Ethics committee approval was Ethics committee approval was obtained for each hospital taking part in obtained for each hospital taking part in the study and all participants signed written the study and all participants signed written consent forms to participate in the study. consent forms to participate in the study. Before randomisation the trial participants Before randomisation the trial participants underwent the following assessments. underwent the following assessments.
Assessment of abdominal pain Assessment of abdominal pain and bowel symptoms and bowel symptoms
The diagnosis of irritable bowel syndrome The diagnosis of irritable bowel syndrome according to the Rome criteria was made according to the Rome criteria was made using the relevant questionnaire, which using the relevant questionnaire, which includes a measure of pain severity, using includes a measure of pain severity, using a visual analogue scale (Drossman a visual analogue scale (Drossman et al et al, , 1995) . Since abdominal pain is the cardinal 1995). Since abdominal pain is the cardinal symptom of the syndrome (Maxton symptom of the syndrome (Maxton et al et al, , 1989; American Gastroenterology Associa-1989; American Gastroenterology Association, 2002) , severity of pain was used as the tion, 2002), severity of pain was used as the prime measure of severity of the syndrome. prime measure of severity of the syndrome. Patients also completed a daily diary Patients also completed a daily diary recording the severity of ten symptoms recording the severity of ten symptoms (nausea, abdominal pain, flatulence, bloat-(nausea, abdominal pain, flatulence, bloating, hard stool, loose stool, urgency, straining, hard stool, loose stool, urgency, straining, incomplete evacuation and mucus), ing, incomplete evacuation and mucus), 5 0 7 5 0 7 Knapp, 1992) ; these included use of day centres, alternative therapies use of day centres, alternative therapies and prescribed medications, and indirect and prescribed medications, and indirect costs such as travel costs and additional costs such as travel costs and additional patient expenditure as a result of the illness, patient expenditure as a result of the illness, non-prescription medication and any non-prescription medication and any additional expenditure relating to houseadditional expenditure relating to housework, childcare or personal care. Indirect work, childcare or personal care. Indirect (loss of productivity) costs were measured (loss of productivity) costs were measured by applying the patient's daily wage to the by applying the patient's daily wage to the number of days lost either through illness number of days lost either through illness or clinic attendance. The total of all healthor clinic attendance. The total of all healthcare, indirect and productivity costs is care, indirect and productivity costs is quoted in the results. quoted in the results.
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Data analysis Data analysis
In preliminary analyses we compared In preliminary analyses we compared patients with and without each psychiatric patients with and without each psychiatric disorder (see Table 1 ) using one-way analydisorder (see Table 1 ) using one-way analysis of variance (ANOVA). Patients with and sis of variance (ANOVA). Patients with and patients without any psychiatric diagnosis, patients without any psychiatric diagnosis, using the criterion of SCAN Index of Defiusing the criterion of SCAN Index of Definition (ID) level 5 or above, were compared nition (ID) level 5 or above, were compared using using w w 2 2 and and t t-tests (see Table 2 ). In the -tests (see Table 2 ). In the main data analysis the predictor variables main data analysis the predictor variables were psychiatric disorder and number of were psychiatric disorder and number of psychiatric diagnoses. The outcome varipsychiatric diagnoses. The outcome variables, recorded both at trial entry and at ables, recorded both at trial entry and at follow-up, were number of days of follow-up, were number of days of restricted activity, SF-36 role limitation restricted activity, SF-36 role limitation (physical) sub-scale score, and total costs. (physical) sub-scale score, and total costs. Age, gender, number of other medical Age, gender, number of other medical conditions for which medication was being conditions for which medication was being taken and severity of abdominal pain taken and severity of abdominal pain (recorded at baseline) were treated as (recorded at baseline) were treated as possible confounders. All data were entered possible confounders. All data were entered and analysed on the Statistical Package for and analysed on the Statistical Package for the Social the Social Sciences, version 11.5. The Sciences, version 11.5. The first, crossfirst, cross-sectional analysis compared sectional analysis compared the patients with and without each psychithe patients with and without each psychiatric diagnosis in terms of impairment atric diagnosis in terms of impairment measured at baseline (i.e. at the time the measured at baseline (i.e. at the time the diagnosis was made) and with costs diagnosis was made) and with costs incurred over the previous year. These incurred over the previous year. These 5 0 8 5 0 8 HRSD, Hamilton Rating Scale for Depression; ID, Index of Definition. HRSD, Hamilton Rating Scale for Depression; ID, Index of Definition. 1. Number of diagnoses compared using one-way analysis of variance (ANOVA). Many patients had more than one psychiatric diagnosis. 1. Number of diagnoses compared using one-way analysis of variance (ANOVA). Many patients had more than one psychiatric diagnosis.
analyses used analysis of covariance analyses used analysis of covariance (ANCOVA) with the possible confounders (ANCOVA) with the possible confounders (listed above) as covariates.
(listed above) as covariates.
Multiple regression was used to identify Multiple regression was used to identify the independent variables associated with the independent variables associated with number of days of restricted activity, number of days of restricted activity, SF-36 role limitation (physical) score and SF-36 role limitation (physical) score and (log) costs. The variables entered into these (log) costs. The variables entered into these regression analyses were: age, gender, regression analyses were: age, gender, marital status, years of education, number marital status, years of education, number of other medical problems, abdominal pain of other medical problems, abdominal pain severity (visual analogue scale), number of severity (visual analogue scale), number of days with pain, and psychiatric disorder days with pain, and psychiatric disorder (depressive and panic disorders and (depressive and panic disorders and neurasthenia). The expectation maxineurasthenia). The expectation maximisation algorithm was used for missing misation algorithm was used for missing data. data.
The prospective analyses assessed The prospective analyses assessed whether the psychiatric diagnosis recorded whether the psychiatric diagnosis recorded at trial entry was associated first, with the at trial entry was associated first, with the number of days of restricted activity and number of days of restricted activity and SF-36 role limitation (physical) score SF-36 role limitation (physical) score recorded at follow-up, and second, with recorded at follow-up, and second, with costs incurred in the 12 months between costs incurred in the 12 months between the end of treatment and follow-up. These the end of treatment and follow-up. These analyses used ANCOVA with treatment analyses used ANCOVA with treatment group (antidepressants, psychotherapy or group (antidepressants, psychotherapy or treatment as usual) and baseline scores as treatment as usual) and baseline scores as covariates, in addition to the variables covariates, in addition to the variables listed in the previous paragraph. listed in the previous paragraph.
Patients with depressive or panic disPatients with depressive or panic disorder were divided into two groups accordorder were divided into two groups according to whether their HRSD score had ing to whether their HRSD score had dropped to 10 or below at 15 months' dropped to 10 or below at 15 months' follow-up, indicating remission (Frank follow-up, indicating remission (Frank et et al al, 1991) . The resulting groups of 'resolved' , 1991). The resulting groups of 'resolved' and 'unresolved' depression were compared and 'unresolved' depression were compared using ANCOVA with the same covariates using ANCOVA with the same covariates as before. To assess whether there was a as before. To assess whether there was a significant treatment by diagnosis effect, significant treatment by diagnosis effect, an analysis was performed which used the an analysis was performed which used the change in SF-36 role limitation score change in SF-36 role limitation score between trial entry and follow-up as the between trial entry and follow-up as the outcome variable. The ANCOVA included outcome variable. The ANCOVA included as covariates age, gender, number of other as covariates age, gender, number of other medical conditions, pain severity, baseline medical conditions, pain severity, baseline SF-36 role limitation score and treatment SF-36 role limitation score and treatment group. The first analysis assessed the effect group. The first analysis assessed the effect of depressive disorder, treatment group of depressive disorder, treatment group (psychotherapy, antidepressants and treat-(psychotherapy, antidepressants and treatment as usual) and the interaction of ment as usual) and the interaction of depressive disorder and treatment group. depressive disorder and treatment group. The second analysis included neurasthenia The second analysis included neurasthenia instead of depressive disorder. instead of depressive disorder.
RESULTS RESULTS
Details of the trial have been published elseDetails of the trial have been published elsewhere (Creed where (Creed et al et al, 2003) and only a , 2003) and only a summary is presented here. A total of 257 summary is presented here. A total of 257 persons (81% of eligible patients) were persons (81% of eligible patients) were recruited to the study. The 60 patients recruited to the study. The 60 patients who declined to enter the study were who declined to enter the study were similar in baseline characteristics to the similar in baseline characteristics to the participants. Of those who participated, participants. Of those who participated, 29% had the diarrhoea-predominant form 29% had the diarrhoea-predominant form of irritable bowel syndrome, 23% had the of irritable bowel syndrome, 23% had the constipation-predominant form and 48% constipation-predominant form and 48% had the general form. During the 3 months had the general form. During the 3 months prior to trial entry 93% were using antiprior to trial entry 93% were using antispasmodic medications, 26% used antidiarspasmodic medications, 26% used antidiarrhoeal medication and 38% were taking rhoeal medication and 38% were taking one or more additional analgesics; 60% one or more additional analgesics; 60% were taking laxatives and 16% motility were taking laxatives and 16% motility stimulants; 29% had used alternative therastimulants; 29% had used alternative therapies previously. The median duration of pies previously. The median duration of bowel problems was 8 years and many bowel problems was 8 years and many patients had been attending the gastroenterpatients had been attending the gastroenterology clinics for years prior to entry into ology clinics for years prior to entry into this study. Abdominal pain occurred on this study. Abdominal pain occurred on most days (mean 24 days per month) and most days (mean 24 days per month) and led to restricted activity on average 12 days led to restricted activity on average 12 days per month. Thirty-four per cent were taking per month. Thirty-four per cent were taking medication for one medical condition and medication for one medical condition and 24% for two or more conditions. Fifty-nine 24% for two or more conditions. Fifty-nine per cent were in full-time or part-time per cent were in full-time or part-time employment, 5% were unemployed but employment, 5% were unemployed but seeking work and 27% were unemployed seeking work and 27% were unemployed through illness; the remainder were retired, through illness; the remainder were retired, homemakers or students. homemakers or students.
Psychiatric disorders Psychiatric disorders
Almost half of the participants (121; 47%) Almost half of the participants (121; 47%) were classified by the SCAN programme as were classified by the SCAN programme as reaching the threshold for psychiatric disreaching the threshold for psychiatric disorder (ID level 5 or above). The numbers order (ID level 5 or above). The numbers of patients assigned to each diagnosis is of patients assigned to each diagnosis is shown in Table 1 . The diagnoses not shown shown in Table 1 . The diagnoses not shown were dysthymia 17 (7%), phobias 39 were dysthymia 17 (7%), phobias 39 (15%), undifferentiated somatoform dis-(15%), undifferentiated somatoform disorder 24 (9%) and drug or alcohol order 24 (9%) and drug or alcohol problems 21 (8%). Many patients had problems 21 (8%). Many patients had more than one disorder: for example, of more than one disorder: for example, of the 74 patients with depressive disorder, the 74 patients with depressive disorder, 16 also had panic disorder, 6 had hypo-16 also had panic disorder, 6 had hypochondriasis and 41 had neurasthenia. chondriasis and 41 had neurasthenia.
Associated features of psychiatric disorders Associated features of psychiatric disorders
Patients with psychiatric disorder (ID level Patients with psychiatric disorder (ID level 5 or above) did not differ significantly from 5 or above) did not differ significantly from the remainder with socio-demographic the remainder with socio-demographic features or symptom type, but they had features or symptom type, but they had more other medical conditions and more more other medical conditions and more severe abdominal pain (Table 2) . Those severe abdominal pain (Table 2) . Those with neurasthenia were younger, and with neurasthenia were younger, and SF-36 role limitation scores were higher SF-36 role limitation scores were higher in women. All subsequent analyses were in women. All subsequent analyses were therefore adjusted for age, gender, number therefore adjusted for age, gender, number of other medical conditions and severity of other medical conditions and severity of abdominal pain. of abdominal pain.
Psychiatric disorders and outcome Psychiatric disorders and outcome measures at baseline measures at baseline At baseline, depressive disorders, panic disAt baseline, depressive disorders, panic disorders and neurasthenia were associated orders and neurasthenia were associated with both restricted activity and impaired with both restricted activity and impaired role functioning; depressive and panic disrole functioning; depressive and panic disorders were associated with increased total orders were associated with increased total costs (Table 3) . No other psychiatric diagcosts (Table 3) . No other psychiatric diagnosis was associated significantly with these nosis was associated significantly with these outcomes. Of the 70 people unable to work outcomes. Of the 70 people unable to work owing to illness, 30 (43%) had depressive owing to illness, 30 (43%) had depressive disorder, compared with 44 out of 187 disorder, compared with 44 out of 187 (24%) of those able to work (OR (24%) of those able to work (OR¼2.4, 2.4, 95% CI 1.4-4.4), and 17 (24%) had panic 95% CI 1.4-4.4), and 17 (24%) had panic disorder, compared with 13 out of 187 disorder, compared with 13 out of 187 (7%) of those able to work (OR (7%) of those able to work (OR¼4.3, 4.3, 95% CI 2.0-9.4). No other psychiatric dis-95% CI 2.0-9.4). No other psychiatric disorder was associated with unemployment order was associated with unemployment through ill health. through ill health.
At baseline the number of psychiatric At baseline the number of psychiatric disorders was associated with number of disorders was associated with number of days of restricted activity, SF-36 role days of restricted activity, SF-36 role limitation (physical) score and total costs limitation (physical) score and total costs in a dose-response fashion (Figs 1-3) . in a dose-response fashion (Figs 1-3) .
Predictors of impairment
Predictors of impairment and costs at baseline and costs at baseline Table 4 displays a summary of the regres- Table 4 displays a summary of the regression analyses to determine the variables sion analyses to determine the variables most closely associated with impairment most closely associated with impairment and costs at baseline. Severity of abdominal and costs at baseline. Severity of abdominal pain was the most strongly associated prepain was the most strongly associated predictor of all outcomes. Panic disorder and dictor of all outcomes. Panic disorder and neurasthenia were also independent predicneurasthenia were also independent predictors of both measures of impairment (days tors of both measures of impairment (days of restricted activity and role limitation of restricted activity and role limitation score); depressive disorder was associated score); depressive disorder was associated with role limitation score and costs. with role limitation score and costs.
Does psychiatric disorder Does psychiatric disorder at baseline predict outcome at baseline predict outcome 15 months later? 15 months later?
Of the three psychiatric diagnoses Of the three psychiatric diagnoses associated with impairment at baseline, associated with impairment at baseline, only one -neurasthenia -was significantly only one -neurasthenia -was significantly associated with number of days per month associated with number of days per month of restricted activity at follow-up: 11.7 days of restricted activity at follow-up: 11.7 days (s.e.m. (s.e.m.¼1.1) compared with 7.5 (s.e.m.
1.1) compared with 7.5 (s.e.m.¼0.8) 0.8) for the patients without neurasthenia for the patients without neurasthenia ( (P P¼0.004, adjusted for treatment group as 0.004, adjusted for treatment group as well as age, gender, number of medical conwell as age, gender, number of medical conditions, severity of abdominal pain at baseditions, severity of abdominal pain at baseline and baseline value of days of restricted line and baseline value of days of restricted activity). Neurasthenia and depressive activity). Neurasthenia and depressive disorder were both associated with SF-36 disorder were both associated with SF-36 5 0 9 5 0 9 Table 3  Table 3 Number of days with restricted activity, SF^36 role limitation (physical) score and total costs for year prior to entry to the trial, by diagnosis Number of days with restricted activity, SF^36 role limitation (physical) score and total costs for year prior to entry to the trial, by diagnosis n n Days of restricted activity (past year) Days of restricted activity (past year) SF^36 role limitation (physical score) SF^36 role limitation (physical score) Total costs including productivity, » Total costs including productivity, » 3.1), adjusted P P¼0.003; ( 0.003; (P P adjusted for similar covariates, except baseadjusted for similar covariates, except baseline value of SF-36 role limitation was used line value of SF-36 role limitation was used instead of days of restricted activity). The instead of days of restricted activity). The number of psychiatric disorders at baseline number of psychiatric disorders at baseline predicted SF-36 role limitation score at predicted SF-36 role limitation score at follow-up (Fig. 2) but not days of restricted follow-up (Fig. 2) but not days of restricted activity or costs (Figs 1, 3) . activity or costs (Figs 1, 3) .
Change over 15 months of the trial Change over 15 months of the trial
Of the 82 patients with depressive and/or Of the 82 patients with depressive and/or panic disorder at baseline, 35 had an HRSD panic disorder at baseline, 35 had an HRSD score of 10 or less at follow-up. This score of 10 or less at follow-up. This resolved group had an adjusted HRSD resolved group had an adjusted HRSD score at baseline of 14.9 (95% CI score at baseline of 14.9 (95% CI 13.1-16.6), compared with a baseline 13.1-16.6), compared with a baseline adjusted HRSD score of 17.0 (95% CI adjusted HRSD score of 17.0 (95% CI 15.5-18.5) for the unresolved group 15.5-18.5) for the unresolved group ( (n n¼47); 47); P P¼0.052. At follow-up the HRSD 0.052. At follow-up the HRSD score for the resolved group had fallen by score for the resolved group had fallen by approximately 10 points to an adjusted approximately 10 points to an adjusted mean of 5.0, whereas the adjusted mean mean of 5.0, whereas the adjusted mean score of the unresolved group remained score of the unresolved group remained the same (Table 5 ). The resolved group the same (Table 5 ). The resolved group experienced significantly fewer days of experienced significantly fewer days of restricted activity than the unresolved restricted activity than the unresolved group during the month prior to followgroup during the month prior to followup assessment. The SF-36 role limitation up assessment. The SF-36 role limitation score showed significantly less impairment score showed significantly less impairment in the resolved group than in the unresolved in the resolved group than in the unresolved group but there was no difference in overall group but there was no difference in overall costs (Table 5) . costs (Table 5 ).
Changes in SF^36 score Changes in SF^36 score with treatment with treatment
The results of the two-way ANCOVA The results of the two-way ANCOVA assessing the effect of depressive disorder assessing the effect of depressive disorder and treatment group indicated that there and treatment group indicated that there was a significant effect of depressive diswas a significant effect of depressive disorder (Fig. 4) . For the 64 patients with order (Fig. 4) (Fig. 5) . The treatment 0.005 (Fig. 5) . The treatment effect was also significant: 15.6 (s.e.m. effect was also significant: 15.6 (s.e.m.¼ 4.7) for psychotherapy, 13.0 (s.e.m. 4.7) for psychotherapy, 13.0 (s.e.m.¼4.4) 4.4) for paroxetine and for paroxetine and 7 71.5 (s.e.m. 1.5 (s.e.m.¼5.1) for 5.1) for treatment as usual respectively; treatment as usual respectively; P P¼0.034. 0.034. There was no significant treatment There was no significant treatment6 6 neurasthenia interaction effect ( neurasthenia interaction effect (P P¼0.52). 0.52).
DISCUSSION DISCUSSION
This is the first study to show the adverse This is the first study to show the adverse effect that individual psychiatric disorders effect that individual psychiatric disorders have on outcome in people with severe irrihave on outcome in people with severe irritable bowel syndrome. Panic and depressive table bowel syndrome. Panic and depressive disorders and neurasthenia were associated disorders and neurasthenia were associated with greater impairment at trial entry; the with greater impairment at trial entry; the first two disorders were also associated first two disorders were also associated with increased costs during the previous with increased costs during the previous 511 511 Fig. 1 Number of days of restricted activity during previous month at baseline and at follow-up by number of Number of days of restricted activity during previous month at baseline and at follow-up by number of psychiatric diagnoses. psychiatric diagnoses. year. At follow-up 15 months later, depresyear. At follow-up 15 months later, depressive disorder and neurasthenia were assosive disorder and neurasthenia were associated with impaired role function. Both ciated with impaired role function. Both depressive disorder and neurasthenia were depressive disorder and neurasthenia were associated with lack of improvement in associated with lack of improvement in SF-36 role limitation sub-scale scores SF-36 role limitation sub-scale scores between trial entry and follow-up. No psybetween trial entry and follow-up. No psychiatric disorder was associated with total chiatric disorder was associated with total costs during the follow-up year. The dosecosts during the follow-up year. The doseresponse relationship between number of response relationship between number of psychiatric disorders and days of restricted psychiatric disorders and days of restricted activity and SF-36 role limitation score activity and SF-36 role limitation score suggests a causal relationship. This is also suggests a causal relationship. This is also supported by our finding that reduction in supported by our finding that reduction in depressive symptoms at follow-up was depressive symptoms at follow-up was associated with reduction in days of associated with reduction in days of restricted activity and improved SF-36 role restricted activity and improved SF-36 role limitation scores. Our multiple regression limitation scores. Our multiple regression analyses demonstrated that depressive and analyses demonstrated that depressive and panic disorders and neurasthenia were panic disorders and neurasthenia were independently associated with baseline independently associated with baseline measures of impairment even after the measures of impairment even after the severity of abdominal pain and other irritaseverity of abdominal pain and other irritable bowel symptoms (recorded in the daily ble bowel symptoms (recorded in the daily diary) had been accounted for. These diary) had been accounted for. These findings support our principal hypotheses findings support our principal hypotheses concerning the association between psychiconcerning the association between psychiatric disorders and impairment of daily atric disorders and impairment of daily function, but offer less support for a direct function, but offer less support for a direct association with costs. association with costs. The psychiatric disorders we identified The psychiatric disorders we identified in our participants were mild in intensity in our participants were mild in intensity compared with those usually treated by compared with those usually treated by psychiatrists or included in trials of deprespsychiatrists or included in trials of depressive disorder. However, the adverse effect sive disorder. However, the adverse effect on outcome is important. Impairment of on outcome is important. Impairment of health-related quality of life in irritable health-related quality of life in irritable bowel syndrome has been reported by bowel syndrome has been reported by others as being comparable with that occurothers as being comparable with that occurring in gastro-oesophageal reflux disease, ring in gastro-oesophageal reflux disease, diabetes and heart disease (Naliboff diabetes and heart disease (Naliboff 2000; Luscombe, 2000; Lea & Whorwell, 2000; Luscombe, 2000; Lea & Whorwell, 2001; El-Serag 2001; El-Serag et al et al, 2002) , but only two , 2002), but only two of these six reports have acknowledged that of these six reports have acknowledged that this impairment could be attributed, in this impairment could be attributed, in part, to co-existing psychiatric disorder part, to co-existing psychiatric disorder (Naliboff (Naliboff et al et al, 1998; Drossman , 1998; Drossman et al et al, , 2000) . 2000).
Our study draws attention to the comOur study draws attention to the component of impairment that is potentially ponent of impairment that is potentially treatable by psychological means. We treatable by psychological means. We found that patients with depressive or neurfound that patients with depressive or neurasthenic disorders who did not receive psyasthenic disorders who did not receive psychotherapy or paroxetine tended to show a chotherapy or paroxetine tended to show a worsening of their SF-36 role limitation worsening of their SF-36 role limitation scores. If psychiatric disorders are not scores. If psychiatric disorders are not recognised and treated in this population, recognised and treated in this population, people with severe irritable bowel people with severe irritable bowel syndrome may suffer unduly and miss time syndrome may suffer unduly and miss time from their work or usual household from their work or usual household activ activities. Since the syndrome was so ities. Since the syndrome was so longlong-standing it is likely that many patients standing it is likely that many patients had had untreated psychiatric disorders for had had untreated psychiatric disorders for months or even years. months or even years.
Our sample was particularly impaired Our sample was particularly impaired because of the way the participants were rebecause of the way the participants were recruited. Even those without a coexisting cruited. Even those without a coexisting psychiatric disorder had low SF-36 scores, psychiatric disorder had low SF-36 scores, reflecting severe abdominal pain and bowel reflecting severe abdominal pain and bowel disturbance (Hahn disturbance (Hahn et al et al, 1997) . For patients , 1997). For patients with psychiatric disorder the very low with psychiatric disorder the very low SF-36 scores were similar to those SF-36 scores were similar to those previously reported in studies of severe copreviously reported in studies of severe comorbid physical and psychiatric disorders morbid physical and psychiatric disorders (Ware (Ware et al et al, 1994; Creed , 1994; Creed et al et al, 2002) . , 2002). Like others, we have found that this Like others, we have found that this combination of physi combination of physical and psychiatric discal and psychiatric disorder leads to high costs because of time order leads to high costs because of time missed from work and expensive healthcare missed from work and expensive healthcare (Druss (Druss et al et al, 2000) . , 2000) . The strengths of the study are its large The strengths of the study are its large sample size, its representative nature (81% sample size, its representative nature (81% of eligible patients were recruited), the of eligible patients were recruited), the detailed measures and its prospective detailed measures and its prospective design. We were able to measure healthcare design. We were able to measure healthcare costs in an objective manner using NHS costs in an objective manner using NHS records, but we have quoted only total records, but we have quoted only total costs (i.e. healthcare and loss of produccosts (i.e. healthcare and loss of productivity) for the sake of brevity. Our tivity) for the sake of brevity. Our measures of impairment of daily living measures of impairment of daily living were self-reported, but great care was taken were self-reported, but great care was taken to record days of restricted activity to record days of restricted activity accurately as part of the costing exercise. accurately as part of the costing exercise. We have reported elsewhere that SF-36 We have reported elsewhere that SF-36 scores are significantly associated with scores are significantly associated with time off work, which provides some time off work, which provides some evidence of the validity of this self-report evidence of the validity of this self-report measure (Creed measure (Creed et al et al, 2003) . The prospec-, 2003) . The prospective design was limited by the fact that tive design was limited by the fact that two-thirds of patients received either antitwo-thirds of patients received either antidepressants or psychotherapy, but we were depressants or psychotherapy, but we were able to show no treatment by diagnosis able to show no treatment by diagnosis interaction. interaction.
The adjustment for severity of abdomThe adjustment for severity of abdominal pain was important because this was inal pain was important because this was the principal predictor of impaired function the principal predictor of impaired function and costs at baseline (see Table 4 ). It and costs at baseline (see Table 4 ). It allowed us to identify the component of allowed us to identify the component of impairment that could be attributed to coimpairment that could be attributed to coexisting psychiatric disorders. We might existing psychiatric disorders. We might have reduced the strength of the associahave reduced the strength of the association, however, because there was a signifition, however, because there was a significant association between psychiatric cant association between psychiatric disorder and abdominal pain severity score. disorder and abdominal pain severity score. Our results may provide a conservative estiOur results may provide a conservative estimate of the association between psychiatric mate of the association between psychiatric disorder and outcome. A further theoretical disorder and outcome. A further theoretical consideration lies in the possibility that the consideration lies in the possibility that the main predictor of outcome is the total main predictor of outcome is the total number of symptoms (physical and psychonumber of symptoms (physical and psychological) and that irritable bowel syndrome logical) and that irritable bowel syndrome and depressive, panic and neurasthenic and depressive, panic and neurasthenic disorders might be seen as overlapping disorders might be seen as overlapping disorders. Although this is possible, the fact disorders. Although this is possible, the fact that severity of abdominal pain and psychithat severity of abdominal pain and psychiatric disorders contribute independently atric disorders contribute independently towards health-related quality of life argues towards health-related quality of life argues for independent influences of these for independent influences of these syndromes. syndromes.
We chose to use the single SF-36 scale We chose to use the single SF-36 scale of physical limitation because of its lack of physical limitation because of its lack of close correlation with neuroticism and of close correlation with neuroticism and its close correlation with patients' views its close correlation with patients' views of the disabling nature of severe irritable of the disabling nature of severe irritable bowel syndrome. We found that it was bowel syndrome. We found that it was the sub-scale (of eight) that most closely the sub-scale (of eight) that most closely correlated with days of restricted activity correlated with days of restricted activity at baseline and at follow-up (data not at baseline and at follow-up (data not shown). The only scale that correlated shown). The only scale that correlated more highly was the physical component more highly was the physical component summary score, but we could not use summary score, but we could not use this score because it is a composite scale this score because it is a composite scale which includes a measure of pain, so that which includes a measure of pain, so that adjustment for severity of pain would have adjustment for severity of pain would have been unsatisfactory. been unsatisfactory.
There were three main weaknesses of There were three main weaknesses of this study. First, this is a secondary analysis this study. First, this is a secondary analysis 513 513 of a data-set that was collected for another of a data-set that was collected for another purpose and patient numbers are not large purpose and patient numbers are not large enough to test adequately all the questions enough to test adequately all the questions regarding healthcare and productivity regarding healthcare and productivity costs. Second, although our sample was costs. Second, although our sample was representative of patients with severe irrirepresentative of patients with severe irritable bowel syndrome in gastroenterology table bowel syndrome in gastroenterology clinics, the results cannot be generalised to clinics, the results cannot be generalised to all patients with this syndrome, most of all patients with this syndrome, most of whom have milder forms of the disorder. whom have milder forms of the disorder. Third, because our patients were in a trial, Third, because our patients were in a trial, two-thirds received an intervention, which two-thirds received an intervention, which has affected outcome; this is not a naturahas affected outcome; this is not a naturalistic study. Our study might have been unlistic study. Our study might have been underpowered to detect a true treatment by derpowered to detect a true treatment by diagnosis interaction. diagnosis interaction. The diagnosis of neurasthenia is similar The diagnosis of neurasthenia is similar to that of chronic fatigue syndrome, and to that of chronic fatigue syndrome, and one other paper has reported that the one other paper has reported that the presence of chronic fatigue in patients with presence of chronic fatigue in patients with irritable bowel syndrome is associated with irritable bowel syndrome is associated with impaired health-related quality of life and impaired health-related quality of life and poor outcome (Simren poor outcome (Simren et al et al, 2001) . It is , 2001). It is recognised that chronic fatigue syndrome, recognised that chronic fatigue syndrome, fibromyalgia and psychiatric disorders fibromyalgia and psychiatric disorders often occur together with irritable bowel often occur together with irritable bowel syndrome (Whitehead syndrome (Whitehead et al et al, 2002) ; such co-, 2002); such comorbidity is associated with greater impairmorbidity is associated with greater impairment than when the syndromes occur singly ment than when the syndromes occur singly (Sperber (Sperber et al et al, 2000) . Neurasthenia is one , 2000). Neurasthenia is one of the most disabling conditions in popuof the most disabling conditions in population studies and the number of days of lation studies and the number of days of restricted activities increased with increasrestricted activities increased with increasing number of comorbid conditions ing number of comorbid conditions (Andrews (Andrews et al et al, 1998) . , 1998). The mechanisms by which depressive, The mechanisms by which depressive, panic and neurasthenic disorders lead to panic and neurasthenic disorders lead to increased impairment and healthcare costs increased impairment and healthcare costs are not totally clear. Because we controlled are not totally clear. Because we controlled for the effect of pain and other medical confor the effect of pain and other medical conditions, these cannot be explanations for ditions, these cannot be explanations for high healthcare and other costs as suggested high healthcare and other costs as suggested previously (Simon previously (Simon et al et al, 1995) . It is likely , 1995). It is likely that psychiatric disorders act in several that psychiatric disorders act in several ways: they may lead to worsening of pain ways: they may lead to worsening of pain and bowel dysfunction, they may exacerand bowel dysfunction, they may exacerbate worry about illness and bodily sympbate worry about illness and bodily symptoms (Gomborone toms (Gomborone et al et al, 1995) and they , 1995) and they may reduce motivation to perform daily may reduce motivation to perform daily tasks. tasks.
The major implication of these results is The major implication of these results is that clinicians should consider whether psythat clinicians should consider whether psychiatric disorders are present in patients chiatric disorders are present in patients with severe irritable bowel syndrome, and with severe irritable bowel syndrome, and if so, appropriate treatment should be if so, appropriate treatment should be offered. Recommendations for treatment offered. Recommendations for treatment of the severe syndrome suggest psychologiof the severe syndrome suggest psychological or behavioural treatments, rather than cal or behavioural treatments, rather than medication directed towards relieving gut medication directed towards relieving gut symptoms (American Gastroenterology symptoms (American Gastroenterology Association, 2002) . This has major implicaAssociation, 2002). This has major implications for healthcare provision. Gastrotions for healthcare provision. Gastroenterologists or primary care physicians enterologists or primary care physicians should be prepared to screen all such should be prepared to screen all such patients for psychiatric disorders and suitpatients for psychiatric disorders and suitably trained health professionals need to ably trained health professionals need to be available for complex cases. The current be available for complex cases. The current referral pattern of highly selected patients referral pattern of highly selected patients within the traditional consultation-liaison within the traditional consultation-liaison model is unlikely to address adequately model is unlikely to address adequately the unmet needs of these patients (Lloyd the unmet needs of these patients (Lloyd & Mayou, 2003) . The professional back-& Mayou, 2003) . The professional background of the mental health professional ground of the mental health professional is less important than readiness to see these is less important than readiness to see these patients, who appear to respond equally patients, who appear to respond equally well to antidepressants prescribed by a well to antidepressants prescribed by a gastroenterologist or general practitioner, gastroenterologist or general practitioner, or psychotherapy administered by a suitor psychotherapy administered by a suitably trained therapist (Creed ably trained therapist (Creed et al et al, 2003 The current system of liaison psychiatry is unlikely to meet this need adequately; close collaboration between psychologists or psychiatrists and gastroenterologists is close collaboration between psychologists or psychiatrists and gastroenterologists is required. required.
LIMITATIONS LIMITATIONS
& & The study is a secondary analysis of data collected as part of a randomised
The study is a secondary analysis of data collected as part of a randomised controlled trial. controlled trial. The study might have been underpowered to detect treatment by diagnosis interaction. interaction.
